Advertisement

Mobile Banner
Mobile Banner
Mobile Banner
Loading...

Ono Pharmaceutical Co., Ltd.

OPHLFPNK
Healthcare
Drug Manufacturers - General
$16.50
$0.25(1.54%)
U.S. Market opens in 9h 45m

Ono Pharmaceutical Co., Ltd. (OPHLF) Stock Competitors & Peer Comparison

See (OPHLF) competitors and their performances in Stock Market.

Peer Comparison Table: Drug Manufacturers - General Industry

Detailed financial metrics including price, market cap, P/E ratio, and more.

SymbolPriceChange %Market CapP/E RatioEPSDividend Yield
OPHLF$16.50+1.54%7.8B23.52$0.71+3.30%
BMYMP$1,002.93+0.29%2T4457.47$0.23+4.11%
RHHBF$483.97-0.62%385.2B23.20$20.86+2.27%
RHHBY$59.18+0.00%382.3B22.74$2.61+1.45%
RHHVF$477.44+0.00%382.1B23.04$20.83+2.39%
NVSEF$166.34+2.86%324.8B23.77$7.16+2.39%
AZNCF$204.20-2.12%316.6B33.86$6.03+1.51%
GLAXF$31.48+0.90%118.6B15.56$1.89+2.83%
SNYNF$93.97-3.89%115B19.76$4.81+4.64%
CHGCY$30.75-4.24%109.4B38.66$0.86+2.56%
1

Stock Comparison

Select a stock to compare (requires JavaScript). Showing default comparison.

OPHLF vs BMYMP Comparison February 2026

OPHLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OPHLF stands at 7.8B. In comparison, BMYMP has a market cap of 2T. Regarding current trading prices, OPHLF is priced at $16.50, while BMYMP trades at $1,002.93.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OPHLF currently has a P/E ratio of 23.52, whereas BMYMP's P/E ratio is 4457.47. In terms of profitability, OPHLF's ROE is +0.08%, compared to BMYMP's ROE of +0.39%. Regarding short-term risk, OPHLF is less volatile compared to BMYMP. This indicates potentially lower risk in terms of short-term price fluctuations for OPHLF.Check BMYMP's competition here

Stock price comparison of stocks in the Healthcare Sector

Loading...

Frequently Asked Questions